Clinical Trial Update: Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the Penumbra System for acute middle cerebral artery stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Penumbra System

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Stroke | Phase 2 | Status: WITHDRAWN